Prescribing patterns of coronary artery aneurysm in Taiwan

BMC Cardiovascular Disorders
Chun-Hui LuShu-Chuan Jennifer Yeh

Abstract

Coronary artery aneurysm (CAA) is a rare disease, and there are limited data on prescribing patterns for CAA. The aim of our study was to investigate prescribing patterns for CAA in Taiwan via the National Health Insurance Research Database (NHIRD). We included all CAA patients in Taiwan from 2005 to 2011. Data from 1 year before and after the CAA diagnosis were used to analyze examinations, comorbidities and prescribing patterns. A total of 1397 patients diagnosed with CAA were enrolled in our study. Most pediatric patients with CAA were diagnosed with Kawasaki disease (95.7%). In pediatric CAA patients, the utilization rates of aspirin and gamma globulins were 82.9 and 53.6%, respectively, after CAA diagnosis. Among the antithrombotic agents, aspirin was used most commonly, followed by dipyridamole (16.9%), heparin (5.8%) and warfarin (4.6%). In adult CAA patients, common comorbidities included hypertension (63.4%), hyperlipidemia (39.6%), and diabetes mellitus (26.1%). Coronary atherosclerosis was identified in 72.5% of adult patients after CAA diagnosis. Antithrombotic agents, particularly aspirin, clopidogrel and heparin, were prescribed more frequently after CAA diagnosis. Among the prescribed medications, aspirin (75.8%)...Continue Reading

References

Feb 1, 1990·Journal of the American College of Cardiology·P A TunickE Glassman
Aug 7, 1986·The New England Journal of Medicine·J W NewburgerS P Sanders
Jan 1, 1983·Circulation·P S SwayeA J Gosselin
May 1, 1993·Circulation·A S DajaniW Wilson
Jul 1, 1997·Progress in Cardiovascular Diseases·M Syed, M Lesch
Aug 1, 1997·Heart·V P DemopoulosD V Cokkinos
May 10, 2003·Revista española de cardiología·Eduardo Pinar BermúdezMariano Valdés Chávarri
Dec 3, 2004·Pediatrics·Luan-Yin ChangUNKNOWN Kawasaki Disease Research Group
Aug 25, 2006·The New England Journal of Medicine·Bruce D Gelb
Oct 27, 2006·Clinical Cardiology·Payam S Pahlavan, Feraydoon Niroomand
Sep 22, 2007·Journal of Cardiovascular Medicine·Serafina ValenteGian Franco Gensini
Oct 17, 2008·Cardiology in Review·Paul Cohen, Patrick T O'Gara
Jan 24, 2009·Journal of the American College of Cardiology·Ravinay BhindiAdrian P Banning
Feb 25, 2009·Pediatrics·Wen-Chan HuangUNKNOWN Kawasaki Disease Research Group
May 30, 2009·Journal of the American College of Cardiology·Fernando AlfonsoCarlos Macaya
Jul 10, 2010·Coronary Artery Disease·Usama BolesMichael Y Henein
Sep 27, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Peng Yeong WoonHo-Chang Kuo
Sep 23, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Jul 3, 2015·Journal of the Saudi Heart Association·Mohammed Atiq Almansori, Hisham Ali Elsayed
Sep 17, 2016·Journal of the American Heart Association·Kevin G FriedmanJane W Newburger
Mar 25, 2017·Clinical Cardiology·Iván J Núñez-GilUNKNOWN CAAR Investigators
Jun 13, 2017·Annals of Translational Medicine·Rami N KhouzamAnthony A Holden
May 17, 2018·BMJ Case Reports·Rohita Reji, Michael Nguyen

❮ Previous
Next ❯

Citations

Sep 17, 2020·Hellenic Journal of Cardiology : HJC = Hellēnikē Kardiologikē Epitheōrēsē·Xiaogang ZhuYujie Zhou

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

SAS

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.